Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$173M |
| 2 |
Amcor
AMCR
|
+$138M |
| 3 |
Microsoft
MSFT
|
+$99.3M |
| 4 |
Amazon
AMZN
|
+$97.5M |
| 5 |
Intel
INTC
|
+$96.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$126M |
| 2 |
Alexandria Real Estate Equities
ARE
|
+$123M |
| 3 |
CHL
China Mobile Limited
CHL
|
+$58.6M |
| 4 |
IDTI
Integrated Device Technology I
IDTI
|
+$45.7M |
| 5 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$44.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.86% |
| 2 | Financials | 14.49% |
| 3 | Healthcare | 12.78% |
| 4 | Industrials | 10.5% |
| 5 | Consumer Discretionary | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Frontdoor
FTDR
$5.89B
| $17.7M | 0.01% |
406,356
+75,465
| +23% | +$2.9M |
|
1227
Stepan Co
SCL
$1.49B
| $17.7M | 0.01% |
192,445
-4,459
| -2% | -$398K |
|
1228
EQT Corp
EQT
$33.9B
| $17.6M | 0.01% |
1,116,216
+62,675
| +6% | +$1.2M |
|
1229
Itron
ITRI
$4.54B
| $17.6M | 0.01% |
282,004
+1,826
| +0.7% | +$101K |
|
1230
Invesco Mortgage Capital
IVR
$804M
| $17.6M | 0.01% |
109,334
-584
| -0.5% | -$94K |
|
|
DOCU
1231
DocuSign
DOCU
$11.4B
| $17.5M | 0.01% |
352,987
+81,447
| +30% | +$4.35M |
|
1232
United Therapeutics
UTHR
$22.6B
| $17.5M | 0.01% |
224,483
+8,366
| +4% | +$782K |
|
1233
CareTrust REIT
CTRE
$9.19B
| $17.5M | 0.01% |
735,751
+238,542
| +48% | +$5.78M |
|
1234
RH
RH
$3.46B
| $17.5M | 0.01% |
151,199
-1,731
| -1% | -$179K |
|
1235
Equitable Holdings
EQH
$14B
| $17.4M | 0.01% |
832,499
+220,882
| +36% | +$4.75M |
|
1236
Trip.com Group
TCOM
$29.1B
| $17.3M | 0.01% |
469,473
-4,132
| -0.9% | -$163K |
|
|
WLL
1237
DELISTED
Whiting Petroleum Corporation
WLL
| $17.3M | 0.01% |
12,364
+2,107
| +21% | +$3.62M |
|
1238
Wendy's
WEN
$1.41B
| $17.3M | 0.01% |
883,960
+11,665
| +1% | +$220K |
|
|
WPG
1239
DELISTED
Washington Prime Group Inc.
WPG
| $17.2M | 0.01% |
501,514
+18,362
| +4% | +$753K |
|
1240
Power Integrations
POWI
$3.53B
| $17.2M | 0.01% |
429,642
+11,668
| +3% | +$426K |
|
1241
Iovance Biotherapeutics
IOVA
$2.89B
| $17.2M | 0.01% |
702,254
+34,480
| +5% | +$519K |
|
1242
Alkermes
ALKS
$8.33B
| $17.1M | 0.01% |
760,660
+51,881
| +7% | +$1.42M |
|
1243
Brookdale Senior Living
BKD
$3.03B
| $17.1M | 0.01% |
2,377,623
-27,022
| -1% | -$178K |
|
|
MANT
1244
DELISTED
Mantech International Corp
MANT
| $17.1M | 0.01% |
260,228
-9,370
| -3% | -$569K |
|
1245
Northwest Natural Holdings
NWN
$2.11B
| $17.1M | 0.01% |
246,498
+2,648
| +1% | +$179K |
|
|
GBT
1246
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $17.1M | 0.01% |
325,365
+11,148
| +4% | +$641K |
|
1247
Otter Tail
OTTR
$3.96B
| $17.1M | 0.01% |
323,778
-4,419
| -1% | -$225K |
|
|
DEA
1248
Easterly Government Properties
DEA
$1.14B
| $17M | 0.01% |
375,142
+48,579
| +15% | +$2.21M |
|
1249
Interactive Brokers
IBKR
$40.7B
| $17M | 0.01% |
1,252,572
+19,208
| +2% | +$260K |
|
1250
Minerals Technologies
MTX
$2.31B
| $17M | 0.01% |
317,030
+9,264
| +3% | +$541K |
|
Similar funds
Charles Schwab's Q2 2019 Portfolio in Review
As of Q2 2019, Charles Schwab held 3,341 positions worth $164B, up 5.3% from $156B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Charles Schwab's Q2 2019 filing shows 147 new, 2,302 increased, 628 reduced and 129 closed positions. Its largest new stake was Dow Inc: 3,280,629 shares worth $162M. The largest sale was DuPont de Nemours, an estimated $126M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2019 buy was Dow Inc: 3,280,629 shares worth $162M.
- Charles Schwab added most to Microsoft in Q2 2019, an estimated $99.3M increase.
- Charles Schwab's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $126M.
- Charles Schwab fully exited China Mobile Limited in Q2 2019, selling an estimated $58.6M.
- Charles Schwab's ten largest holdings make up 15% of its $164B portfolio in Q2 2019.
- Charles Schwab opened 147 new positions and closed 129 in Q2 2019.
- Charles Schwab's portfolio value rose 5.3% quarter-over-quarter to $164B.
Based on Charles Schwab's 13F filing for Q2 2019, filed 9 Aug 2019.